Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

One in six patients in phase II oncology clinical trials received a treatment that was eventually approved by the FDA, ...

Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...

Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer ...

This new review article highlights the crucial role of GATA6, a transcription factor, in pancreatic ductal adenocarcinoma ...

In the landscape of non-small cell lung cancer (NSCLC) management, the integration of biomarkers for precision medicine has ...

Transcriptional profiling of patients with metastatic hormone-sensitive prostate cancer to uncover specific signatures linked to the transition from androgen-dependent to androgen-independent ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ...